| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addition of histone deacetylase inhibitors does not improve prognosis in patients with myelodysplastic syndrome and acute myeloid leukemia compared with hypomethylating agents alone: A systematic review and meta-analysis of seven prospective cohort studies
|
Pan, Tingting
|
|
2018
|
71 |
C |
p. 13-24
|
artikel
|
| 2 |
Are clonal cells circulating in the peripheral blood of myelodysplastic syndrome?: Quantitative comparison between bone marrow and peripheral blood by targeted gene sequencing and fluorescence in situ hybridization
|
Hwang, Sang Mee
|
|
2018
|
71 |
C |
p. 92-94
|
artikel
|
| 3 |
Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group
|
Papageorgiou, Sotirios G.
|
|
2018
|
71 |
C |
p. 55-59
|
artikel
|
| 4 |
Cytoplasmic CD3 expression in infant acute megakaryoblastic leukemia: A new ambiguous lineage subtype?
|
Rossi, Jorge Gabriel
|
|
2018
|
71 |
C |
p. 6-12
|
artikel
|
| 5 |
Economic burden of elderly patients with acute myeloid leukemia treated in routine clinical care in the United States
|
Bell, Jill A.
|
|
2018
|
71 |
C |
p. 27-33
|
artikel
|
| 6 |
Editorial Board
|
|
|
2018
|
71 |
C |
p. ii
|
artikel
|
| 7 |
Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes
|
Gurnari, C.
|
|
2018
|
71 |
C |
p. 89-91
|
artikel
|
| 8 |
Factors associated with a prolonged hospital stay during induction chemotherapy in newly diagnosed high risk pediatric acute lymphoblastic leukemia
|
Warrick, Kasper
|
|
2018
|
71 |
C |
p. 36-42
|
artikel
|
| 9 |
Higher body mass index is associated with better survival in patients with myelodysplastic syndromes
|
Jabbar, Kausar J.
|
|
2018
|
71 |
C |
p. 63-66
|
artikel
|
| 10 |
Hodgkin lymphoma of the gastrointestinal tract in patients with inflammatory bowel disease: Portrait of a rare clinical entity
|
Barzilai, Merav
|
|
2018
|
71 |
C |
p. 1-5
|
artikel
|
| 11 |
Incidence and survival of therapy related myeloid neoplasm in United States
|
Guru Murthy, Guru Subramanian
|
|
2018
|
71 |
C |
p. 95-99
|
artikel
|
| 12 |
Management of melanoma in patients with chronic lymphocytic leukemia
|
Archibald, William J.
|
|
2018
|
71 |
C |
p. 43-46
|
artikel
|
| 13 |
Morphologic dysplasia in Myelodysplastic Syndromes: How accurate are morphologists?
|
Bennett, John M.
|
|
2018
|
71 |
C |
p. 34-35
|
artikel
|
| 14 |
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A
|
Kelaidi, C.
|
|
2018
|
71 |
C |
p. 67-74
|
artikel
|
| 15 |
Pediatric acute lymphoblastic leukemia—Conquering the CNS across the choroid plexus
|
März, Martin
|
|
2018
|
71 |
C |
p. 47-54
|
artikel
|
| 16 |
Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms
|
Berdeja, J.
|
|
2018
|
71 |
C |
p. 82-88
|
artikel
|
| 17 |
Prognostic impact of ASXL1 mutations in patients with myelodysplastic syndromes and multilineage dysplasia with or without ring sideroblasts
|
Mangaonkar, Abhishek A.
|
|
2018
|
71 |
C |
p. 60-62
|
artikel
|
| 18 |
Prognostic impact of pretreatment albumin to globulin ratio in patients with diffuse large B-cell lymphoma treated with R-CHOP
|
Kim, Seok-Hyun
|
|
2018
|
71 |
C |
p. 100-105
|
artikel
|
| 19 |
Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma
|
Salem, Dalia A.
|
|
2018
|
71 |
C |
p. 106-111
|
artikel
|
| 20 |
Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells
|
Ogata, Kiyoyuki
|
|
2018
|
71 |
C |
p. 75-81
|
artikel
|
| 21 |
Should more MDS patients be treated with immune-suppression?
|
Almeida, Antonio
|
|
2018
|
71 |
C |
p. 25-26
|
artikel
|
Tijdschrift beschrijving